Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Phase III, Randomized, Sham-controlled Clinical Trial

NCT07693335 is registered in ClinicalTrials.gov with Taiwan Municipal An-Nan Hospital-China Medical University as lead sponsor.

NCT NCT07693335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07693335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Acupuncture on Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Phase III, Randomized, Sham-controlled Clinical Trial
Lead sponsor
Taiwan Municipal An-Nan Hospital-China Medical University
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2021
Completion date
June 30, 2025
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acupuncture, chemotherapy-induced peripheral neuropathy (cipn)